Literature DB >> 10452913

Presence of CLA-1 and HDL binding sites on syncytiotrophoblast brush border and basal plasma membranes of human placenta.

J Lafond1, M C Charest, J F Alain, L Brissette, A Masse, J Robidoux, L Simoneau.   

Abstract

It is now known that rapid placental and fetal development is associated with elevated levels of circulating high density lipoprotein (HDL) in pregnant women. The main structure implicated in the maternal-fetal exchange is the syncytiotrophoblast, composed of a brush border membrane (BBM), facing the mother, and a basal plasma membrane (BPM), facing the fetus. In order to understand the mechanisms controlling the placental and fetal supplies of cholesterol, we purified both BBM and BPM and verified the presence of HDL binding sites in these membranes. Binding studies using(125)I-HDL(3)show a single affinity binding site on BPM which has a dissociation constant (K(d)) of 3.45+/-0.43 microg protein/ml and a maximal binding capacity (B(max)) of 5.46+/-1.69 microg protein/mg membrane proteins. In BBM, we observed two affinity binding sites, one with a K(d)of 0.62+/-0.03 microg protein/ml and another one with a K(d)of 6.57+/-0.87 microg protein/ml. Their B(max)values were 0.54+/-0.11 and 2.34+/-0.39 microg of HDL(3)/mg membrane proteins, respectively. CLA-1, a putative HDL-receptor of 85 kDa, was detected on both BPM and BBM, together with two apo A-l binding sites of 110 and 96 kDa on BPM and BBM, respectively. These results provide further evidence that human placenta possesses specific sites for HDL binding, underlining the important role of maternal HDL in the transfer of cholesterol from the maternal circulation to the placenta and the fetus. Copyright 1999 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10452913     DOI: 10.1053/plac.1999.0412

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  8 in total

Review 1.  Hormones and human trophoblast differentiation: a review.

Authors:  André Malassiné; Laurent Cronier
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 2.  Placental Origins of Chronic Disease.

Authors:  Graham J Burton; Abigail L Fowden; Kent L Thornburg
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

3.  Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient mice.

Authors:  H E Miettinen; H Rayburn; M Krieger
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

4.  Uptake of dietary retinoids at the maternal-fetal barrier: in vivo evidence for the role of lipoprotein lipase and alternative pathways.

Authors:  Lesley Wassef; Loredana Quadro
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

Review 5.  Abnormal sterol metabolism in holoprosencephaly.

Authors:  Dorothea Haas; Maximilian Muenke
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-02-15       Impact factor: 3.908

Review 6.  Role of lectin-like oxidized low density lipoprotein-1 in fetoplacental vascular dysfunction in preeclampsia.

Authors:  Felipe A Zuniga; Valeska Ormazabal; Nicolas Gutierrez; Valeria Aguilera; Claudia Radojkovic; Carlos Veas; Carlos Escudero; Liliana Lamperti; Claudio Aguayo
Journal:  Biomed Res Int       Date:  2014-07-06       Impact factor: 3.411

Review 7.  Physiology and Pathophysiology of Steroid Biosynthesis, Transport and Metabolism in the Human Placenta.

Authors:  Waranya Chatuphonprasert; Kanokwan Jarukamjorn; Isabella Ellinger
Journal:  Front Pharmacol       Date:  2018-09-12       Impact factor: 5.810

Review 8.  Human Placental Intracellular Cholesterol Transport: A Focus on Lysosomal and Mitochondrial Dysfunction and Oxidative Stress.

Authors:  Maria Jose Yañez; Andrea Leiva
Journal:  Antioxidants (Basel)       Date:  2022-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.